Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04951336 · ClinicalTrials.gov registry record · NA
RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT04951336 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 90 participants.
The verdict
NCT04951336, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), for use as an adjunct to vaccination for COVID-19 in a general population at the time of COVID-19 vaccination.
Interventions
- DIETARY_SUPPLEMENT FoTv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-06-10 |
| Est. Completion | 2022-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04951336
The ClinicalTrials.gov registry entry for NCT04951336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FoTv is the first listed.
NCT04951336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04951336 about?
NCT04951336 is a clinical study titled "RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination". This is a randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), for use as an adjunct to vaccination for COVID-19 in a general population at the time of COVID-19 vaccination.
What is the current status of trial NCT04951336?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2021-06-10. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT04951336?
The interventions under investigation include: FoTv (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04951336?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.